BioSpace News Archive

Business

Novanta Inc. Schedules Earnings Release and Conference Call for Tuesday, November 09, 2021

Novanta Inc. will release its third quarter 2021 results on Tuesday, November 09, 2021.

October 11, 2021
·
1 min read
Drug Development

Ascletis Announces Results of the Phase IIa trial of ASC22 (Envafolimab) in Patients with Chronic Hepatitis B to be Presented in Oral Parallel Session at The Liver Meeting® 2021 by American Association for the Study of Liver Diseases

Ascletis Pharma Inc. (HKEX: 1672) announces today that the results of Phase IIa trial of subcutaneously administered PD-L1 antibody ASC22 (Envafolimab) in patients with chronic hepatitis B (CHB) will be presented in oral parallel session at The Liver Meeting® 2021 by American Association for the Study of Liver Diseases (AASLD).

October 11, 2021
·
3 min read
Business

EpimAb Biotherapeutics Strengthens Scientific Advisory Board with Addition of Andrew X. Zhu

EpimAb Biotherapeutics, a clinical stage biotech company specializing in bispecific antibodies, today announced the appointment of Andrew X. Zhu, M.D., Ph.D., to the company’s Scientific Advisory Board.

October 11, 2021
·
3 min read